Home Search
reverse - search results
If you're not happy with the results, please do another search
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click here to receive post-merger report.
INNOVUS LIVE CHART
TRADING...
Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase from Prior Quarter.
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...
Internet Stock Review Adds MySize (MYSZ) $0.45 to Watch List.
Short Term Turbulence Creates Potential Entry Point at $0.45.
Investors appeared to react swiftly to an 8K, which looked a lot like they were facing...
Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & Heartburn.
Innovative Innovus now has Three Shots on Goal with non-prescription drugs which have come off patent including a new competitor to Prilosec ® ....
Innovus (INNV) in Silicon Review Interview.
POISED FOR INNOVATION.
The Silicon Review is the world’s most trusted online and print community for business & technology professionals. Our community members include thought-provoking...
Innovus (INNV) Conference Call Transcript.
Q1 2019 Results, 5/15/19.
Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM ET
Company Participants
Bassam Damaj - President and CEO
Ryan...
Adding Innovus Pharma (INNV) $2.50 to Watch List.
Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup.
We're adding...